AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 30 of 93

31 PVR ≤2 WU PVR >2 to <5 WU PVR 5–8 WU that decreases to <5 WU on PAH therapy PVR 5–8 WU on PAH therapy 2b Expert PAH and ACHD care; possible closure 1 ASD closure 2a ASD closure 2a ASD closure Avoid ASD closure 3: Harm * Therapy, PAH-directed medical therapy. All ASD closure recommendations assume the patient has no evidence of significant left heart disease. ACHD indicates adult congenital heart disease; ASD, atrial septal defect; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; PVR, pulmonary vascular resistance; Qp:Qs, pulmonary- to-systemic blood flow ratio; RV, right ventricle; and WU, Wood units.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease